The new mandate for multiple risk reduction
Reducing the morbidity and mortality associated with cardiovascular (CV) disease is becoming as much a public health challenge as it is a research challenge. Advances in vascular biology have enhanced our understanding of the biochemical and physiological processes by which hypertension and dyslipidemia, the two most common risk factors for CV disease,1
interact in a synergistic manner to increase
The critical challenge is to implement this knowledge.
References are listed at the end of the Data Alert.
Synergistic actions of hypertension and dyslipidemia on endothelial function
Download 04DA-Multiple-Risk.ppt (6 slides - 0.2MB)